140 related articles for article (PubMed ID: 20610983)
1. Azole antimycotics and drug interactions in the perioperative period.
Saari TI; Olkkola KT
Curr Opin Anaesthesiol; 2010 Aug; 23(4):441-8. PubMed ID: 20610983
[TBL] [Abstract][Full Text] [Related]
2. Management of drug and food interactions with azole antifungal agents in transplant recipients.
Dodds-Ashley E
Pharmacotherapy; 2010 Aug; 30(8):842-54. PubMed ID: 20653361
[TBL] [Abstract][Full Text] [Related]
3. Frequency of potential azole drug-drug interactions and consequences of potential fluconazole drug interactions.
Yu DT; Peterson JF; Seger DL; Gerth WC; Bates DW
Pharmacoepidemiol Drug Saf; 2005 Nov; 14(11):755-67. PubMed ID: 15654717
[TBL] [Abstract][Full Text] [Related]
4. New generation azole antifungals in clinical investigation.
Girmenia C
Expert Opin Investig Drugs; 2009 Sep; 18(9):1279-95. PubMed ID: 19678798
[TBL] [Abstract][Full Text] [Related]
5. Update on drug interactions with azole antifungal agents.
Lomaestro BM; Piatek MA
Ann Pharmacother; 1998 Sep; 32(9):915-28. PubMed ID: 9762380
[TBL] [Abstract][Full Text] [Related]
6. Interactions between antifungal and antiretroviral agents.
Hughes CA; Foisy M; Tseng A
Expert Opin Drug Saf; 2010 Sep; 9(5):723-42. PubMed ID: 20345324
[TBL] [Abstract][Full Text] [Related]
7. Modification of vincristine dosing during concomitant azole therapy in adult acute lymphoblastic leukemia patients.
Harnicar S; Adel N; Jurcic J
J Oncol Pharm Pract; 2009 Sep; 15(3):175-82. PubMed ID: 19282418
[TBL] [Abstract][Full Text] [Related]
8. Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents.
Brüggemann RJ; Alffenaar JW; Blijlevens NM; Billaud EM; Kosterink JG; Verweij PE; Burger DM
Clin Infect Dis; 2009 May; 48(10):1441-58. PubMed ID: 19361301
[TBL] [Abstract][Full Text] [Related]
9. Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting.
Morera T; Gervasini G; Carrillo JA; Benitez J
Ann Pharmacother; 2004; 38(7-8):1301-6. PubMed ID: 15178735
[TBL] [Abstract][Full Text] [Related]
10. Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450.
Gubbins PO
Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1411-29. PubMed ID: 21995615
[TBL] [Abstract][Full Text] [Related]
11. Azole antifungals: 35 years of invasive fungal infection management.
Allen D; Wilson D; Drew R; Perfect J
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
[TBL] [Abstract][Full Text] [Related]
12. [Azole antifungal agents in the prevention of fungal infections in neutropenic patients and bone marrow graft recipients].
Lortholary O; Dupont B
Ann Med Interne (Paris); 1997; 148(3):258-67. PubMed ID: 9255336
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological considerations for azole antifungal drug management in cystic fibrosis lung transplant patients.
Billaud EM; Guillemain R; Berge M; Amrein C; Lefeuvre S; Louët AL; Boussaud V; Chevalier P
Med Mycol; 2010 Nov; 48 Suppl 1():S52-9. PubMed ID: 21067331
[TBL] [Abstract][Full Text] [Related]
14. Second-generation azole antifungal agents.
Kale P; Johnson LB
Drugs Today (Barc); 2005 Feb; 41(2):91-105. PubMed ID: 15821782
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for invasive fungal infections.
Dodds Ashley ES
Pharmacotherapy; 2006 Jun; 26(6 Pt 2):55S-60S. PubMed ID: 16716123
[TBL] [Abstract][Full Text] [Related]
16. Azole antimycotics--a highway to new drugs or a dead end?
Musiol R; Kowalczyk W
Curr Med Chem; 2012; 19(9):1378-88. PubMed ID: 22257053
[TBL] [Abstract][Full Text] [Related]
17. Azoles and antidepressants: a mini-review of the tolerability of co-administration.
Roussos P; Lewis RE; Kontoyiannis DP
Mycoses; 2009 Sep; 52(5):433-9. PubMed ID: 19207836
[TBL] [Abstract][Full Text] [Related]
18. Antifungal prophylaxis with azoles in high-risk, surgical intensive care unit patients: a meta-analysis of randomized, placebo-controlled trials.
Vardakas KZ; Samonis G; Michalopoulos A; Soteriades ES; Falagas ME
Crit Care Med; 2006 Apr; 34(4):1216-24. PubMed ID: 16484923
[TBL] [Abstract][Full Text] [Related]
19. Multiple cytochrome P-450s involved in the metabolism of terbinafine suggest a limited potential for drug-drug interactions.
Vickers AE; Sinclair JR; Zollinger M; Heitz F; Glänzel U; Johanson L; Fischer V
Drug Metab Dispos; 1999 Sep; 27(9):1029-38. PubMed ID: 10460803
[TBL] [Abstract][Full Text] [Related]
20. Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients.
Gubbins PO
Curr Opin Infect Dis; 2007 Dec; 20(6):579-86. PubMed ID: 17975407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]